AK · State regulatory reference

Alaska.

Moderate

Alaska tracks federal defaults with no distinctive peptide/GLP-1 rule and no documented state enforcement. AS 08.64.364 (prescription of drugs without physical examination) permits physicians and PAs to prescribe non-controlled drugs without an in-person exam if a provider in the practice is available for follow-up and records are offered to the patient's primary care provider; it bars prescribing solely via internet questionnaire or email to a patient with no existing relationship. 12 AAC 40.943 adopts AMA and FSMB model telemedicine standards by reference. For compounding, 12 AAC 52.440 points to the Board's own 'Compounding Practices' pamphlet rather than incorporating current USP <795>/<797>, and no state-specific GLP-1/semaglutide restriction was found.

Last reviewed · 2026-05-25 · verified entry

Agencies

Medical board

Alaska Medical Board

https://www.commerce.alaska.gov/web/cbpl/professionallicensing/statemedicalboard.aspx ↗

Pharmacy board

Alaska Board of Pharmacy

https://www.commerce.alaska.gov/web/cbpl/professionallicensing/boardofpharmacy.aspx ↗

TPC notes

Telehealth

An initial visit plus prescribing can occur via telehealth without a prior in-person exam for non-controlled drugs under AS 08.64.364 (follow-up care available and PCP records offered); the older in-person-first requirement is not the current rule. Prescribing solely from an internet questionnaire or email to a patient with no existing relationship remains prohibited.

Compounding

Alaska has not adopted current USP <795>/<797> by reference; 12 AAC 52.440 points to the Board of Pharmacy's dated 'Compounding Practices' pamphlet (incorporating USP 797 was an open agenda item as of the Board's Nov 2023 meeting). No Alaska-specific GLP-1/semaglutide compounding restriction was located.

Sources